Artrya Limited (ASX:AYA)

Market Cap	545.39M
Revenue (ttm)	28.00K
Net Income (ttm)	-16.41M
Shares Out	158.08M
EPS (ttm)	-0.18
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	446,186
Average Volume	844,956
Open	3.490
Previous Close	3.500
Day's Range	3.430 - 3.590
52-Week Range	0.425 - 4.020
Beta	0.62
RSI	55.88
Earnings Date	Feb 19, 2026

About Artrya

Artrya Limited, a medical technology company, engages in the development and commercialization of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia. The company offers Salix, a suite ifcloud-based software that uses artificial intelligence to automate the detection of coronary artery disease from coronary computed tomography angiography scans to identify and manage patients at risk of a heart attack. Artrya Limited was incorporated in 2018 and is based in West Perth, Australia.

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2018
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: AYA